Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole Blood
NCT02330081
Blood Safety
Bergen, Norway
View Trial DetailsNCT Number: NCT02513966
There is a decrease in the amount of blood components used during cardiac surgery in the last four years. As the hemovigilance team of the investigators' Hospital the investigators want to find out the causes and effects of this decrease.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5years
Universitaire Ziekenhuizen KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02330081
Blood Safety
Bergen, Norway
View Trial DetailsNCT06142825
Blood Transfusion
Minneapolis, Minnesota, United States
View Trial DetailsNCT07603999
Blood Transfusion, Mortality
Gainesville, Florida, United States
View Trial DetailsNCT07094646
Anemia, Anemia, Hemolytic
Jinja, Uganda
View Trial Details